Skip to main content

Table 2 Univariate and multivariate analyses of prognostic factors for disease-free and overall survival of stage II and III colon carcinoma patients

From: High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis

  DISEASE-FREE SURVIVAL
  Univariate Analysis Multivariate Analysis
Prognostic factors HR 1 (95% CI) 2 p value HR (95% CI) p value
Stage III vs II 2.55 (1.41-4.60) 0.002 2.77 (1.45-5.28) 0.002
HCA2 relative score (+3/+2/-3/-2 vs others) 2.50 (0.18-5.31) 0.02 2.94 (1.36-6.34) 0.006
MEM-E/02 absolute score (0/1/2 vs 3) 1.90 (1.05-3.45) 0.03 1.82 (0.96-3.45) 0.06
T (3/4 vs 1/2) 1.26 (0.56-2.82) 0.58   
Grading (2/3 vs 1) 1.95 (0.47-8.04) 0.36   
HCA2 absolute score (0/1 vs 2/3) 1.47 (0.77-2.79) 0.25   
HC10 absolute score (2/3 vs 0/1) 2.40 (0.74-7.74) 0.14   
L31 absolute score (0/1 vs 2/3) 1.36 (0.73-2. 57) 0.33   
  OVERALL SURVIVAL
  Univariate Analysis Multivariate Analysis
Prognostic factors HR 1 (95% CI) 2 p value HR (95% CI) p value
Stage III vs II 2.78 (1.45-5.34) 0.002 2.49 (1.23-5.04) 0.01
HCA2 relative score (+3/+2/-3/-2 vs others) 3.09 (1.43-6.69) 0.004 3.55 (1.61-7.87) 0.002
MEM-E/02 absolute score (0/1/2 vs 3) 1.96 (1.01-3.81) 0.05 1.81 (0.90-3.63) 0.09
T (3/4 vs 1/2) 1.41 (0.55-3.61) 0.48   
Grading (2/3 vs 1) 1.57 (0.38-6.52) 0.54   
HCA2 absolute score (0/1 vs 2/3) 1.66 (0.83-3.31) 0.15   
HC10 absolute score (2/3 vs 0/1) 1.91 (0.59-6.22) 0.28   
L31 absolute score (0/1 vs 2/3) 1.21 (0.60-2.44) 0.61   
  1. 1 HR: hazard risk
  2. 2 CI: 95% confidence interval
  3. Significant correlations boldface